emcardioНеотложная кардиология и кардиоваскулярные рискиEmergency Cardiology and Cardiovascular Risks journal2616-633XБелорусский государственный медицинский университет10.51922/2616-633X.2026.10.1.2843emcardio-349Research ArticleИНТЕРЕСНЫЙ КЛИНИЧЕСКИЙ СЛУЧАЙAN INTERESTING CLINICAL CASEЭкстремальная гипертриглицеридемия у пациентки с дебютом сахарного диабета: клинический случайExtreme hypertriglyceridemia in a patient with the onset of diabetes mellitus: clinical caseМакарцоваТ. И.MakartsovaT. I.

Гродно

tatibo1@yandex.ruСурмачЕ. М.SurmachK. M.

Гродно

tatibo1@yandex.ruГолышкоВ. С.HalyshkaV. S.

Гродно

tatibo1@yandex.ruФроловВ. A.FrolovV. A.

Гродно

tatibo1@yandex.ruСинкевичИ. А.SinkevichI. A.

Гродно

tatibo1@yandex.ruБалюкП. В.BalukP. V.

Гродно

tatibo1@yandex.ruКнышА. В.KnyshA. V.

Гродно

tatibo1@yandex.ruУО «Гродненский государственный медицинский университет»БеларусьGrodno State Medical UniversityBelarusУЗ «Городская клиническая больница № 3»БеларусьGrodno Clinical Hospital No. 3Belarus20262107202610128432848Copyright © Макарцова Т.И., Сурмач Е.М., Голышко В.С., Фролов В.A., Синкевич И.А., Балюк П.В., Кныш А.В., 20262026Макарцова Т.И., Сурмач Е.М., Голышко В.С., Фролов В.A., Синкевич И.А., Балюк П.В., Кныш А.В.Makartsova T.I., Surmach K.M., Halyshka V.S., Frolov V.A., Sinkevich I.A., Baluk P.V., Knysh A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://emcardio.bsmu.by/jour/article/view/349

Высокая распространённость ожирения и сахарного диабета в рамках метаболического синдрома открывает перед нами новые вызовы – повышение триглицеридов, повышение холестерина, не-липопротеинов высокой плотности, липопротеинов (а), что приводит к росту атеросклеротических сердечно-сосудистых заболеваний. Экстремально высокая гипертриглицеридемия выявляется редко, манифестирует у пациентов с сахарным диабетом в виде таких осложнений, как острый панкреатит. В статье представлен клинический случай 42-летней женщины с сахарным диабетом 2 типа, диагностированным впервые, ассоциированным с экстремальной гипертриглицеридемией, обсуждена тактика ведения, терапия.

The high prevalence of obesity and diabetes mellitus within the framework of metabolic syndrome opens up new challenges for us – increased triglycerides, elevated non-HDL cholesterol and Lp(a), this leading to an increase in atherosclerotic cardiovascular diseases. Extremely high hypertriglyceridemia is rarely detected, and it manifests in patients with diabetes mellitus in the form of complications such as acute pancreatitis. The article presents a clinical case of a 42-year-old woman with newly diagnosed type 2 diabetes associated with extreme hypertriglyceridemia, management and therapy having been discussed.

дислипидемиягипертриглицеридемиялипопротеин (а)сердечно-сосудистый рисклипидснижающая терапияdyslipidemiahypertriglyceridemialipoprotein (a)cardio-vascular risklipid lowering treatmentReferences2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) / F. Mach, C Baigent, A. L. Catapano [et al.] // European Heart Journal. – 2020. – Vol. 41, iss. 1. – P. 111-188. – doi: 10.1093/eurheartj/ehz455.Mach F., Baigent C., Catapano A.L. et al. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020, vol. 41(1), pp. 111-188. doi: 10.1093/eurheartj/ehz455.Нерешенные проблемы дислипидемии и резидуального сердечно-сосудистого риска / В. С. Гуревич, Н. А. Козиолова, М. В. Ежов [и др.] // Атеросклероз и дислипидемии. – 2022. – № 1 (46). – С. 31-38. – doi: 10.34687/2219-8202.JAD.2022.01.0003.Gurevich V.S., Koziolova N.A., Ezhov M.V. et al. Unsolved problems of dyslipidemia and residual cardiovascular risk. Journal of atherosclerosis and dyslipidemias. 2022, vol. 1, no. 46, pp. 31-39. doi:10.34687/2219-8202.JAD.2022.01.0003. (in Russian).Toth, P. Triglycerides and atherosclerosis: bringing the association into sharper focus / P. Toth // Journal of the American College of Cardiology. – 2021. – Vol. 77, iss. 24. – P. 3042–3045. – doi: 10.1016/j.jacc.2021.04.058.Toth P.P. Triglycerides and atherosclerosis: bringing the association into sharper focus. J Am Coll Cardiol. 2021, vol. 77(24), pp. 3042-3045. doi: 10.1016/j.jacc.2021.04.058.Singh, A. K. Triglyceride and cardiovascular risk: A critical appraisal / A. K. Singh, R. Singh // Indian journal of endocrinology and metabolism. – 2016. – Vol. 20, iss. 4. – P. 418-28. – doi: 10.4103/2230-8210.183460.Singh A.K., Singh R. Triglyceride and cardiovascular risk: A critical appraisal. Indian J Endocrinol Metab. 2016, vol. 20(4), pp. 418-28. doi: 10.4103/2230-8210.183460.Toth, P. P. Targeting hypertriglyceridemia to mitigate cardiovascular risk: a review / P. P. Toth, P. K. Shah, N. E. Lepor // American journal of preventive cardiology. – 2020. –Vol. 3. – P. 100086. – doi: 10.1016/j.ajpc.2020.100086.Toth P.P., Shah P.K., Lepor N.E. Targeting hypertriglyceridemia to mitigate cardiovascular risk: A review. Am J Prev Cardiol. 2020, vol. 3, pp. 100086. doi: 10.1016/j.ajpc.2020.100086.Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in Diabetes / A. S. Alexopoulos, A. Qamar, K. Hutchins [et al.] // Current dia-n betes reports. – 2019. – Vol. 19, iss. 4. – P. 13. – doi: 10.1007/s11892-019-1136-3.Alexopoulos A.S., Qamar A., Hutchins K. et al. Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in Diabetes. Curr Diab Rep. 2019, vol. 19(4), pp. 13. doi: 10.1007/s11892-019-1136-3.Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women / P. M. Ridker, M. V. Moorthy, N. R. Cook [et al.] // The New England journal of medicine. – 2024. – Vol. 391, iss. 22. – P. 2087-2097. – doi: 10.1056/NEJMoa2405182.Ridker P.M., Moorthy M.V., Cook N.R. et al. Inflammation, Cholesterol, Lipoprotein(a), and 30-year cardiovascular outcomes in women. N Engl J Med. 2024, vol. 391(22), pp. 2087-2097. doi: 10.1056/NEJMoa2405182.Severe Hypertriglyceridemia in Patients with Type 2 Diabetes Mellitus Participating in the AMD Annals Initiative / G. T. Russo, V. Manicardi, A. Rocca [et al.] // Metabolic syndrome and related disorders. – 2024. – Vol. 22, iss. 9. – P. 661-668. – doi: 10.1089/met.2024.0093.Russo G.T., Manicardi V., Rocca A. et al. Severe hypertriglyceridemia in patients with type 2 diabetes mellitus participating in the AMD Annals Initiative. Metab Syndr Relat Disord. 2024, vol. 22(9), pp. 661-668. doi: 10.1089/met.2024.0093.Cumulative exposure to hypertriglyceridemia and risk of type 2 diabetes in young adults / M. K. Lee, K. Han, B. Kim [et al.] // Diabetes research and clinical practice. – 2024. – Vol. 208. – P. 111109. – doi: 10.1016/j.diabres.2024.111109.Lee M.K., Han K., Kim B. et al. Cumulative exposure to hypertriglyceridemia and risk of type 2 diabetes in young adults. Diabetes Res Clin Pract. 2024, vol. 208, pp. 111109. doi: 10.1016/j.diabres.2024.111109.Severe hyperlipemia-induced pseudoerythrocytosis - Implication for misdiagnosis and blood transfusion: A case report and literature review / X. C. Zhao, B. Ju, N. Wei [et al.] // World journal of clinical cases. – 2020. – Vol. 8, iss. 19. – P. 4595-4602. – doi: 10.12998/wjcc.v8.i19.4595.Zhao X.C., Ju B., Wei N. et al. Severe hyperlipemia-induced pseudoerythrocytosis - Implication for misdiagnosis and blood transfusion: A case report and literature review. World J Clin Cases. 2020, vol. 8(19), pp. 4595-4602. doi: 10.12998/wjcc.v8.i19.4595.Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study / J. Li, Z. Nie, Z. Ge [et al.] // Lipids in health and disease. – 2022. – Vol. 21, iss. 1. – P. 77. – doi: 10.1186/s12944-022-01691-1.Li J., Nie Z., Ge Z., et al. Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study. Lipids Health Dis. 2022, vol. 21(1), pp. 77. doi: 10.1186/s12944-022-01691-1.Fishman, M. L. Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence? / M. L. Fishman, M. A. McLaughlin, V. Fuster // Womens Health (Lond). – 2009. – Vol. 5, iss. 6. – P. 617-23. – doi: 10.2217/whe.09.59.Fishman M.L., McLaughlin M.A., Fuster V. Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence? Womens Health (Lond). 2009, vol. 5(6), pp. 617-23. doi: 10.2217/whe.09.59.Marassi, M. The cardio-renal-metabolic connection: a review of the evidence / M. Marassi, G. P. Fadini // Cardiovascular diabetology. – 2023. – Vol. 22, iss. 1. – P. 195. – doi: 10.1186/s12933-023-01937-x.Marassi M., Fadini G.P. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol. 2023, vol. 22(1), pp. 195. doi: 10.1186/s12933-023-01937-x.Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies / X. Ye, W. Kong, M. I. Zafar, L. L. Chen // Cardiovascular diabetology. – 2019. – Vol. 18, iss. 1. – P. 48. – doi: 10.1186/s12933-019-0851-z.Ye X., Kong W., Zafar M.I., Chen L.L. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019, vol. 18(1), pp. 48. doi: 10.1186/s12933-019-0851-z.Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study / F. P. B. Kristensen, D. H. Christensen, M. B. Mortensen [et al.] // Cardiovascular diabetology. – 2023. – Vol. 22, iss. 1. – P. 187. – doi: 10.1186/s12933-023-01921-5.Kristensen F.P.B., Christensen D.H., Mortensen M.B. et al. Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study. Cardiovasc Diabetol, 2023, vol. 22(1), pp. 187. doi: 10.1186/s12933-023-01921-5.Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes / Y. Wang, Y. Fang, D. J. Magliano [et al.] // Cardiovascular research. – 2023. – Vol. 119, iss. 3. – P. 826-834. – doi: 10.1093/cvr/cvac124.Wang Y., Fang Y., Magliano D.J. et al. Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes. Cardiovasc Res, 2023, vol. 119(3), pp. 826-834. doi: 10.1093/cvr/cvac124.Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024 / American Diabetes Association Professional Practice Committee // Diabetes Care. – 2024. – Vol. 47, suppl. 1. – P. S179-S218. – doi: 10.2337/dc24-S010.American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024. Diabetes Care, 2024, vol. 47(Suppl 1), pp. S179-S218. doi: 10.2337/dc24-S010.

The authors declare that there are no conflicts of interest present.